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Malaria is a serious infectious disease caused by parasites of the Plasmodium genus that affect different vertebrate
hosts. Severe malaria leads to host death and involves different pathophysiological phenomena such as anemia,
thrombocytopenia and inflammation. Nitric oxide (NO) is an important effector molecule in this disease, but little is
known about its role in avian malaria models. Plasmodium gallinaceum- infected chickens were treated with
aminoguanidine (AG), an inhibitor of inducible nitric oxide synthase, to observe the role of NO in the pathogenesis
of this avian model. AG increased the survival of chickens, but also induced higher parasitemia. Treated chickens
demonstrated reduced anemia and thrombocytopenia. Moreover, erythrocytes at different stages of maturation,
heterophils, monocytes and thrombocytes were infected by Plasmodium gallinaceum and animals presented a
generalized leucopenia. Activated leukocytes and thrombocytes with elongated double nuclei were observed in
chickens with higher parasitemia; however, eosinophils were not involved in the infection. AG reduced levels of
hemozoin in the spleen and liver, indicating lower inflammation. Taken together, the results suggest that AG
reduced anemia, thrombocytopenia and inflammation, explaining the greater survival rate of the treated chickens.Introduction
Malaria remains one of the most globally-important infec-
tious diseases, particularly in terms of morbidity, mortality
and deleterious economic consequences. This disease
affects half a billion people worldwide every year and more
than 2 million people die yearly from severe malaria
[1]. This disease presents a number of different clinical
symptoms, with a variety of pathological consequences
associated with severe malaria, such as acute respiratory
distress, renal failure, severe anemia and cerebral malaria,
all of which can arise from infection with Plasmodium
falciparum [1,2].* Correspondence: renato@uenf.br
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reproduction in any medium, provided the orSeveral studies on the complex physiopathology of
malaria have been published, but the cellular and molecular
mechanisms involved in its pathogenesis remain unclear.
Thus, experimental models have been established in order
to address these issues and to develop better therapeutic
procedures. Different malaria models with peculiar charac-
teristics have been developed in monkeys, mice, rats and
birds [3,4]. Investigations regarding avian hemoprotozoa
have provided many fundamental discoveries about malaria,
including the existence of the extra-erythrocytic stages
occurring with Plasmodium gallinaceum infections [5-7].
Plasmodium gallinaceum (Apicomplexa: Haemospororida)
infects chickens and was first described by Brumpt in 1935,
constituting a versatile model for studying alternative treat-
ments for human malaria [5,7,8]. This model dominated
studies of the biology of the parasite and chemotherapeutic
research from 1890 until 1940 [4,7]. Recently, this model
has come back into use [4,8-14].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.veterinaryresearch.org/content/44/1/8Several hypotheses exist to explain the mechanisms
involved in malaria pathogenesis, such as anemia,
thrombocytopenia and inflammation. One inflammatory
mediator studied in malaria is nitric oxide (NO) [13,15-17].
NO is cytotoxic and cytostatic to blood stage malaria
parasites in vitro [18-20], but the precise mechanism
by which NO mediates an in vivo effect is not known.
NO, when produced in large quantities by the inducible
isoform of the NO synthase, has the potential to kill a
variety of pathogens [21-23]. Whether NO controls, or
not, acute parasitemia in malaria is unclear [24]. Increased
production of endogenous NO during blood stage malaria
has been correlated with protection against P. chabaudi
infection in mice [18]. However, several studies show the
dichotomous role of NO in malaria pathogenesis. Ghigo
et al. demonstrated that neural changes in murine malaria
increase cytokine levels and NO production by inducible
NO synthase [15]. Evidence of this activation was demon-
strated in the brain tissues of children with fatal malaria
[17]. However, in the murine model, other authors
have shown severe malaria in animals knocked out
for inducible NO synthase [16]. In a previous study,
we showed a positive correlation between NO production,
by macrophages of chickens, with increased infection by
P. gallinaceum [13]; however, little is known about the
role of this radical in avian malaria.
Thrombocytopenia is also found in humans [25-27]
and mice [28,29] malaria and was recently described
in an avian malaria model in chickens that were
experimentally infected with P. juxtanucleare [12],
clearly indicating an important role for platelets/
thrombocytes in the pathogenesis of this disease.
Platelets are activated during the course of the mal-
aria infection [26] and release microparticles that
modulate the cytoadherence of parasitized erythro-
cytes on the brain endothelium [30,31], with ensuing
platelet aggregation [30,32]. Thrombocytopenia is
thought to occur as a consequence of platelet con-
sumption and is probably part of the pathogenesis of
malaria [26].
We have observed that macrophages of chickens
infected with P. gallinaceum produce high amounts of
NO [13]. As such, we evaluated the role of NO during
the infection of chickens with P. gallinaceum by blocking
NO production using aminoguanidine (AG) treatment.
This treatment increased the survival of chickens during
the acute phase of the infection, reduced anemia and
thrombocytopenia, and lowered levels of hemozoin
pigment in the spleen and liver. Moreover, blood lympho-
cytes, heterophils, monocytes and thrombocytes became
activated and atypical thrombocytes were observed. These
results suggest that the increased survival of AG- treated
infected chickens was mediated by reduced anemia,
thrombocytopenia and inflammation.Material and methods
Parasite and chickens
The protozoan P. gallinaceum, strain 8A, was kindly
provided by Dr Antoniana Krettli from the Centro de
Pesquisa Renè Rachou, Fundação Oswaldo Cruz, Minas
Gerais, Brazil. The parasite was maintained by successive
passages in chickens. Hubbard chickens (1 day-old) were
acquired from commercial establishments in Marechal
Floriano, Espírito Santo, Brazil. Chickens were maintained
in cages at the animal house of the Universidade Estadual
do Norte Fluminense, Rio de Janeiro, Brazil, with water
and a balanced feed (cocciodiostatic free), ad libitum.
Chickens were infected on the 35th day.
This study was carried out in strict accordance with
the Brazilian Law #11794/08. The animal studies proto-
col was reviewed and approved by the Committee on
the Ethics of Animal Experiments of the Universidade
Estadual do Norte Fluminense (Permit Number: 100).
Treatment with AG and infection with Plasmodium
gallinaceum
Daily treatment with AG (25 mg/Kg) by the intraperitoneal
route started two days before infection with the parasite.
The dose was based on previous studies [33-35]. For infec-
tion, chickens were inoculated intramuscularly with 5 × 106
erythrocytes parasitized by P. gallinaceum [13]. Chickens
were clinically examined and monitored daily from the 4th
day post-infection (dpi); the assessment of the clinical
manifestations was notated without score subdivision.
Experimental groups and blood collection
Chickens were distributed randomly into experimental
groups (G1: noninfected; G2: noninfected treated with
AG; G3: infected untreated; G4: infected treated with
AG). G1 and G2 had 5 chickens and G3 and G4 had 12
chickens. All chickens in G1 and G2 had their blood
collected every four days after infection. G3 and G4 were
divided into two subgroups of 6 chickens each. The
subgroups were bled every four days, but with a 2-day dif-
ference between these subgroups; thus, 6 chickens from
G3 and G4 were bled every other day. Blood was collected
from the wing vein starting on the 4th dpi through to the
28th dpi. For hematology assays, all chickens from every
group and subgroup had their blood (1 mL) collected with
ethylenediaminetetraacetic acid as the anticoagulant.
For serum biochemistry, three chickens from every
group and subgroup had their blood (2 mL) collected
without anticoagulant to obtain serum. Three independent
experiments were performed; figure legends indicate the
number of repetitions.
Determination of parasitemia and temperature
Blood smears were obtained daily from a drop of blood
taken from the nail of the bird; the sample was then








































































Figure 1 Survival, temperature and parasitemia of chickens infected with Plasmodium gallinaceum. (A) Survival of infected chickens treated
(■) or not (●) with aminoguanidine. Mantel-Cox test p= 0.0021. (B) Correlation of temperature and parasitemia of noninfected, chronic and infected
chickens treated (■,▲,●, respectively) or not (□, Δ, ○, respectively). (C) Parasitemia of chickens that chronified, when treated (■, n= 17) or not (●, n= 8).
(D) Parasitemia of untreated chickens that died (♦, n= 1; ■, n= 6;▲, n= 5; □, n= 2; ●, n= 1; ○, n= 1). (E) Parasitemia of treated chickens that died
(♦, n= 2; ■, n= 1;▲, n= 1; ●, n= 1; ○, n= 1). *Statistically significant (p < 0.05) in relation to the respective untreated value. Data are from two
independent experiments, except “B” which is from one representative experiment.
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http://www.veterinaryresearch.org/content/44/1/8Giemsa stained and observed under an Axioplan Zeiss
microscope by bright field microscopy. Parasitemia was
estimated as a percentage by counting the number of
parasites in about 1000 erythrocytes found in 10 micro-
scopic fields using an immersion objective (100×) lens
[13]. Parasitemia of immature erythrocytes, monocytes,
heterophils and thrombocytes was also estimated as a
percentage by counting at least 100 cells in three indi-
vidual blood smears. The birds’ temperatures in Celsiuswere evaluated daily between 3:00 and 4:00 pm by
inserting a digital thermometer in the chickens’ cloaca.
Classic hematology
Packed cell volume was determined by the microhematocrit
technique. Hemoglobin concentration was determined by a
colorimetric method following sample centrifugation
(1600 × g, 5 min) before reading [36]. Blood was diluted
























Figure 2 Plasma nitric oxide levels (μM) of chickens infected with Plasmodium gallinaceum, treated (black bars) or not (gray bars), with
aminoguanidine and grouped by parasitemia ranges (PR). For noninfected chickens: n = 15 for untreated and n = 13 for treated; for PR of <1:
n = 6 for untreated and n = 4 for treated; for PR of 1–10: n = 6 for untreated and n = 9 for treated; for PR of 11–20: n = 4 for untreated and treated;
for PR of 21–30: n = 4 for untreated and treated; for chronic chickens: n = 18 for untreated and n = 10 for treated. ## Statistically significant (p < 0.01)
in relation to the noninfected value. *Statistically significant (p < 0.05) in relation to the respective treated value. Data are from one
representative experiment.
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volume (MCV) and mean corpuscular hemoglobin concen-
tration (MCHC) were calculated [37]. Thrombocytes and
leukocytes were counted simultaneously in a Neubauer
chamber by diluting (1:50) blood with PBS containing
0.01% brilliant blue cresyl [36]. Later the percentage of
thrombocytes in relation to leukocytes was determined by
counting 100 cells in a blood smear [38]. The differential
count of leukocytes was made in blood smears stained with
Giemsa; 100 cells were counted per slide. Cells, infected or
not, were observed under an Axioplan Zeiss microscope
equipped with polarized light and images were captured
with a digital camera (Axiovision MRc5). The percentage of
immature erythrocytes and toxic heterophils was estimated
by counting 300 and 100 cells, respectively, in at least 3
individual blood smears of chickens with high parasitemia.
The cell size of thrombocytes, lymphocytes and monocytes
was estimated in control (noninfected), low (15%) and high
(50%) parasitemia chickens (5 animals each). Images of cells
from individual blood smears were captured with the digital
camera. The area of at least 250 to 170 for thrombocytes,
240 to 50 for lymphocytes and 100 to 25 for monocytes
was estimated using the Axiovision software.
Serum biochemistry
In the laboratory, serum was aliquoted and stored at −70°C
until the assays. Alanine aminotransferase (ALT), aspartate
aminotransferase (AST), lactate dehydrogenase (LDH),
alkaline phosphatase (ALP), cholesterol, urea, uric
acid and creatinine were analyzed using standard kits
(Labtest Diagnostica SA, Brazil) with the aid of a
spectrophotometer (BTS 310, Biosystems).Plasma nitric oxide production
Production of NO in plasma was evaluated by the
Griess reaction [39] after converting nitrate to nitrite
by incubation of plasma in nitrate reductase (purified
from Aspergillus) in the presence of NADPH [40].
Ethylenediaminetetraacetic acid was used as an anticoagu-
lant to avoid precipitation that may occur when the Griess
solution is added to heparinized plasma. The mixture was
incubated for 3 h at room temperature and 100 μL of the
sample was mixed with 100 μL of the Griess reagent on a
96-well plate. After 10 min, the samples were read using a
spectrophotometer (540 nm). The concentrations of nitrite
in the samples were determined by the use of a standard
curve with serial dilutions of sodium nitrite solution, and
values were expressed in μM.
Culture and staining of thrombocytes
Chicken leukocytes were separated from total blood on
a 60% Percoll solution, as previously reported [41].
Blood from chickens, infected or noninfected, treated or
not with AG, were used. Briefly, 3 mL of blood was
collected into heparinized syringes, diluted (1:1) with
Dulbecco’s Modified Eagle’s Medium (DMEM) layered
on top of the Percoll solution and centrifuged at 600 g
for 20 min without a break. The diluted plasma was
discarded, and the buffy coat collected and washed.
Cells, consisting mainly of lymphocytes, monocytes and
thrombocytes, were resuspended in DMEM, adjusted
to 2 × 107 cells/mL and seeded on glass coverslips
(150 μL) in 24-well plates for tissue culture. After 1 h
of culture (adherence time) at 37°C in a 5% CO2






















Figure 3 Red cell hematological parameters of chickens infected with Plasmodium gallinaceum, treated (black bars) or not (gray bars),
with aminoguanidine and grouped by parasitemia ranges (PR). (A) Number of erythrocytes. (B) Hematocrit. (C) Hemoglobin concentration.
(D) MCV. (E) MCHC. For noninfected chickens: n = 22 for untreated and treated; for PR of 1–10: n = 24 for untreated and n = 30 for treated; for PR
of 11–20: n = 14 for untreated and n = 16 for treated; for PR of 21–30: n = 5 for untreated and n = 11 for treated; for PR of 31–40: n = 6 for
untreated and n = 7 for treated; for PR of 41–50: n = 4 for untreated and n = 6 for treated; for PR of > 50: n = 4 for untreated and treated; for
chronic chickens: n = 44 for untreated and n = 46 for treated. ## Statistically significant (p < 0.01) in relation to the noninfected value. *Statistically
significant (p < 0.05 or p < 0.01 for **) in relation to the respective untreated value. Data are from two independent experiments.
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added for 24 h of culture. Some coverslips were
removed, and the cells were fixed in 4% formaldehyde
in PBS and processed for immunofluorescence (see
below) or stained with Giemsa, dehydrated in
acetone-xylol and mounted in Entellan. Morphological
observations were carried out under an Axioplan
Zeiss microscope.Immunofluorescence analysis of thrombocytes
After fixing, cell monolayers were washed with PBS and
incubated with ammonium chloride (100 mM) in PBS
for 30 min. Cells were further incubated with 1.5% bo-
vine serum albumin (BSA) in PBS (PBS/BSA) and incu-
bated for 1 h in primary antibody diluted 1:10 in PBS/
BSA. The primary antibody (anti-thrombocyte 11C3)
was a supernatant of hybridoma cultures and a kind gift
FA B C D
E G H
Figure 4 Blood of chickens infected with Plasmodium gallinaceum presented immature erythrocytes that were also infected.
Erythrocyte at prophase (A), prometaphase (B), anaphase (C) and telophase (D) were seen. Mature (E) and immature erythrocytes (F, G, H)
were infected (arrowheads).
Macchi et al. Veterinary Research 2013, 44:8 Page 6 of 14
http://www.veterinaryresearch.org/content/44/1/8from Dr Kanellopoulos-Langevin C. [42]. This monoclo-
nal antibody recognizes the chicken integrin CD41/61,
which is a heterodimeric cell surface protein expressed
on chicken thrombocytes [42]. The cells were washed,
incubated for 10 min in PBS/BSA, and further incubated
with anti-mouse secondary antibody conjugated with
TRITC diluted 1:100 in PBS/BSA. The cells were washed
and mounted with ProlongGoldW with DAPI. Slides were
observed under an Axioplan Zeiss microscope equipped
with fluorescence.
Histopathology
Chickens, at the acute phase of the infection, were sacri-
ficed; spleens and livers were dissected and fixed in 10%
buffered formalin. Samples were routinely processed in
alcohol and xylol and embedded in paraffin. Paraffin
blocks were cut using a rotational microtome. Sections
of 5 μm were stained with hematoxylin and eosin (H&E)
and observed under an Axioplan Zeiss microscope.
Data analyses
Values are expressed as means and standard deviation.
The results are also shown by correlating survival or
parasitemia with days; due to the great variability of
hematological values, the results for NO serum levels,
hematology and biochemical assays of chickens were
grouped by parasitemia range. The number of chickens
in each parasitemia range of AG treated and untreated
chickens are given in the figure legends. Survival
was presented as a Kaplan-Meyer graph with the
Mantel-Cox test analysis. The AG treated and untreated
chickens were analyzed statistically using the Wilcoxontest; for comparison of noninfected and infected chickens
the ANOVA test followed by the Dunnet test were used.
The threshold of significance was p ≤ 0.05 or p ≤ 0.01, as
indicated in the figure legends. Comparisons of cell size
between thrombocytes, lymphocytes and monocytes of
noninfected, low or high parasitemia chickens were
performed using the Kruskal–Wallis test (α = 0.05).
Results
Infected erythrocytes were found on day 6 dpi in
AG-treated and untreated chickens. Only 33% of the
AG-treated chickens died, while 66% of the untreated
group succumbed during the experiment (Figure 1A).
Typical clinical avian malaria manifestations, such as
apathy, lack of appetite, cachexia, paleness of the cocks-
comb and legs, nystagmus, retracted body position with
beak down and involuntary muscular face contraction were
observed. These manifestations were less evident in chick-
ens treated with AG. One animal from the untreated group
presented abnormal rhythm vocalization. An additional
movie file shows this in more detail (see Additional file 1).
Body temperature raised (fever) similarly and on the day of
death was equal in both chicken groups (Figure 1B).
AG-treated chickens that chronified during the experi-
ment presented a higher parasitemia peak (Figure 1C).
Moreover, the AG-treated chickens presented an approxi-
mately 34% higher parasitemia on the day of death, in
comparison to the untreated chickens (Figure 1D, E). Thus,
treatment reduced clinical manifestations and increased
survival but resulted in higher parasitemia.
NO plasma levels did not change at low parasitemia (< 1)












Figure 6 Absolute numbers of total leukocytes (A),
lymphocytes (B), monocytes (C) and heterophils (D) of chickens
infected with Plasmodium gallinaceum treated (black bars) or
not (gray bars) with aminoguanidine grouped by parasitemia
range (PR). For noninfected chickens: n = 11 for untreated and
n = 12 for treated; for PR of 1–10: n = 17 for untreated and n = 19 for
treated; for PR of 11–20: n = 8 for untreated and n = 16 for treated;
for PR of 21–30: n = 3 for untreated and n = 6 for treated; for PR of
31–40: n = 5 for untreated and n = 5 for treated; for PR of 41–50:
n = 4 for untreated and n = 4 for treated; for PR of >50: n = 3 for
untreated and n = 4 for treated; for chronic chickens: n = 22 for
untreated and n = 16 for treated. # Statistically significant (p < 0.05)
in relation to the noninfected value; * Statistically significant





Figure 5 Plasmodium gallinaceum infects monocytes (A, B),
heterophils (C, D) and thrombocytes (E, F). (A, C, E) Leukocytes
from blood smears stained with Giemsa. (B, D, F) Same visual field
observed by polarized microscopy; note the birefringent malaria
pigment. Bar = 10 μm.
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http://www.veterinaryresearch.org/content/44/1/8However, plasma NO levels positively correlated with
moderate and higher parasitemia in chickens not treated
with AG (Figure 2). As expected, the administration of
AG reduced NO in plasma (Figure 2). In animals with
chronic infection, the NO plasma levels were similar to
those of noninfected chickens, independently of AG
treatment (Figure 2). Thus, systemic NO production
was controlled by AG treatment.
Chickens were examined by classical hematology
during the time course of the experiments. All three
values of the red series reduced with higher parasitemia
(Figure 3A-C). However, chickens treated with AG
presented higher values, some of which were statistically
significant, for the number of erythrocytes (Figure 3A)
and hemoglobin concentration (Figure 3C), in relation
to the untreated group. In addition, AG-treated chickens
recovered their erythrocyte numbers when they became
chronically infected (Figure 3A). The MCV increased
with higher parasitemia for untreated chickens, while
the AG-treated chickens had similar values in relation to
noninfected chickens, except at the higher parasitemia
range (Figure 3D). The MCHC reduced with higher
parasitemia, but AG treatment increased these values in
Macchi et al. Veterinary Research 2013, 44:8 Page 8 of 14
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the higher parasitemia range (Figure 3E). In short, the
AG treatment lowered the severity of the anemia caused
by the infection.
Observations of peripheral blood smears of AG treated
or untreated chickens with parasitemia above 35%
revealed the presence of 19.2% of immature erythrocytes
some undergoing the process of cell division (Figure 4A-D).
Most of the infected erythrocytes were in a mature stage
(Figure 4E), but 13.0% of immature erythrocytes in different
phases of the cell cycle were also infected (Figure 4F-H).
Some blood cells were also found infected in chickens
with parasitemia above 40%: 1.0% of the monocytes
(Figure 5A, B), 5.0% of heterophils (Figure 5C, D)
and 4.2% of thrombocytes (Figure 5E, F). No differences
were found between AG treated or untreated chickens.
As parasitemia increased, AG treated and untrea-
ted chickens presented a trend towards leucopenia
(Figure 6A). Treated chickens that survived the infection
recovered the normal amount of leukocytes, while un-
treated chickens presented higher levels of leukocytes
(Figure 6A). The most abundant leukocytes were lym-
phocytes, followed by heterophils and monocytes. A
significant reduction in the total number of lympho-
cytes was detected in the two highest parasitemia
ranges in both groups of chickens (Figure 6B). Mono-
cytopenia was observed in both groups in the lowA B C
E F
H I
Figure 7 Leukocytes from chickens, infected or noninfected with Plas
noninfected (A, B) and infected chickens with low (C) or high parasitemia
Heterophils were normal in noninfected (G) and low parasitemia (H) anima
observed. Bar = 10 μm.parasitemia range (Figure 6C). At moderate parasitemia,
monocytopenia was detected only in the untreated group
(Figure 6C). Normal numbers of monocytes were registered
in untreated chickens at the higher parasitemia range; how-
ever, treated chickens presented a lower number of mono-
cytes (Figure 6C). A decrease in the number of heterophils
was observed in both groups of chickens when higher para-
sitemia was achieved (Figure 6D). Chronified chickens
tended to recover the number of these three leukocytes
(Figure 6B-D). Eosinophils disappeared from the blood in
chickens at moderate and higher parasitemia ranges (not
shown).
Blood lymphocytes and heterophils changed their morph-
ology as parasitemia increased; however, monocytes and
eosinophils did not (Figure 7). Monocytes of noninfected
chickens presented purple, kidney-shaped nuclei and a
light-blue cytoplasm with few deep-blue areas (Figure 7A).
No statistical difference of monocyte size was found for
noninfected, low or high parasitemia chickens (not shown).
As expected, lymphocytes of noninfected chickens had a
low cytoplasm nucleus ratio and were smaller in relation to
monocytes (Figure 7B); their mean area was 57.4 μm2.
Infection caused lymphocytes to increase in size with a
tendency to lower the cytoplasm-nucleus ratio; irregular
staining of the cytoplasm was more frequent (Figure 7C,
D); their mean area was 72.1 μm2, statistically different
from lymphocytes of noninfected chickens. EosinophilsD
G
J
modium gallinaceum. Monocyte (A) and lymphocytes (B-D) of
(D). Eosinophils from noninfected (E) and infected (F) chickens.









Figure 8 Absolute numbers of thrombocytes (A) of chickens
infected with Plasmodium gallinaceum, treated (black bars) or
not (gray bars), with aminoguanidine and grouped by
parasitemia range (PR). Thrombocytes of infected chickens stained
with Giemsa in blood smears (B - D) and after culture for 1 h (E - H).
Thrombocytes became larger and with more vacuoles when
parasitemia was higher (B - D). (E) Normal thrombocytes with typical
vacuoles (arrow). (F) Pyknotic thrombocytes. Note condensed
chromatin (arrows). Atypical thrombocytes with long mononucleus
(G) and two nuclei (arrows) (H) are seen. Bar = 10 μm. For the
number of chickens by PR, number of experiments and significance
of symbols, see Figure 6.
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change was seen when this cell type was compared between
noninfected (Figure 7E) and low parasitemia infected chick-
ens (Figure 7F). Heterophils of noninfected (Figure 7G) and
moderately-infected chickens (Figure 7H) had similar
morphology; but chickens with higher parasitemia pre-
sented normal (not shown), toxic band (Figure 7I) and toxic
lobulated heterophils (Figure 7J). In chickens with high
parasitemia, toxic heterophils represented 21.8% of the het-
erophil population. No clear changes in the morphology of
these leukocytes were found during the infection between
AG treated and untreated chickens.
Untreated chickens had a significant thrombopenia that
correlated to higher parasitemia, which was not seen in the
AG treated chickens (Figure 8A). Thrombocytes also
presented morphological changes with higher parasitemia,
becoming larger with an increase in the cytoplasmic region
where vacuoles are located (Figure 8B-D). The mean area
of the thrombocytes was 30.9 μm2 for noninfected, 52.8
μm2 for low parasitemia, and 70.6 μm2 for higher parasit-
emia, all statistically significant. Thrombocytes were cul-
tured to better characterize its morphology. Thrombocytes
of noninfected chickens were cultured for 1 h, after which
they presented a spread nucleus with patches of stained
chromatin, as well as spread cytoplasm with evident
vacuoles (Figure 8E). A few thrombocytes (< 4%) had a
pyknotic nucleus with retracted cytoplasm (Figure 8F), indi-
cating apoptosis, as reported before [65]. However, infec-
tion of the chickens induced the appearance of atypical
thrombocytes with well spread cytoplasm with, either a
long nucleus (Figure 8G) or two nuclei (Figure 8H).
These atypical cells were confirmed as thrombocytes
by immunofluorescence (Figure 9). Cells with typical
thrombocyte morphology, but with long or two nuclei
(Figure 9A, B) were recognized by the 113C monoclonal
antibody specific for chicken thrombocytes [42]. Normal
and pyknotic thrombocytes were also positive for this anti-
body after 24 h in culture, but macrophages were negative
(Figure 9C, D). Blood smears also revealed thrombocytes
with double nuclei, but were rarely seen (Figure 9E-G).
Serum biochemistry revealed a reduction in the ALT
levels in chickens of both groups in the low parasitemia
ranges (Figure 10A). AST values increased in untreated
chickens in the higher parasitemia range (Figure 10B). A
reduction in ALP values was detected as parasitemia
increased; chronic chickens also showed a reduced level of
this enzyme and untreated animals presented a lower value
(Figure 10C). Values for LDH, cholesterol, urea, and uric
acid tended to increase with higher parasitemia for both
chicken groups (not shown). No apparent changes in either
chicken groups were detected for creatinine (not shown).
Spleens of noninfected chickens presented clear white
and red pulp with normal tissue display (not shown).
However, chickens with higher parasitemia presentedspleen with lymphocyte depletion that was accentuated
in AG treated chickens and moderate in untreated ones
(Figure 11A, C). Treated chickens also presented less
malaria pigment in the spleen (Figure 11B, D). Livers of
untreated chickens with higher parasitemia presented a
rich inflammatory infiltrate, composed of mononuclear
cells and rare heterophils, with perivascular location
(Figure 11E). Coagulation necrosis was also observed




Figure 9 Atypical thrombocytes were positive for the anti-thrombocyte antibody, 11C3, and were rarely detected in stained blood
smears. Fluorescence (A, C) and differential interference contrast (B, D) microscopy after labeling cells with the anti-thrombocyte antibody 11C3;
red staining is the antibody labeling and blue is DNA. Cells were cultured for 1 (A, B) and 24 h (C, D). Bright field microcopy of stained blood
smears (E, F, G). (A, B) Atypical thrombocytes with one nucleus (arrowhead) or two nuclei (arrow) cultured for 1 h were positive for 11C3. (C, D)
Normal (arrow) and pyknotic (arrowhead) thrombocytes were positive for 11C3; macrophage (long arrow) was negative. (E- G) Atypical
thrombocytes with two nuclei were also observed in blood smears of chickens with high parasitemia. Bar = 10 μm, bar in A and E, is the same
for B, C, D and F, G, respectively.
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pigment (Figure 11F, H) in the liver.
Discussion
To better understand the role of NO in avian malaria, AG
was used to pharmacologically block this radical previous
to the infection of chickens with P. gallinaceum. AG treat-
ment increased survival and reduced the levels of the
clinical manifestation of chickens, when compared to the
untreated group. Furthermore, treated chickens had higherparasitemia, indicating that survival is not directly related
to parasitemia. Higher temperature (fever) was observed
similarly between both groups. Infection caused anemia,
but treatment with AG ameliorated the red series
parameters. In addition, thrombocytopenia and in-
flammation, as seen by blood leukocyte morphology
and tissue hemozoin, increased with infection, but
were partially reverted by AG treatment. Collectively,
these results indicate that AG treatment increased the





Figure 11 Spleen and liver of aminoguanidine treated chickens
have less malaria pigment during the acute phase of the
infection. (A) Spleen section of untreated chickens stained with
H&E, showing lymphocyte depletion (arrows). (B) Same visual field
observed by polarized microscopy. (C) Spleen section of treated
chickens stained with H&E, showing extensive lymphocyte depletion.
(D) Same visual field observed by polarized microscopy. Note less
birefringent material in treated chickens. (E) Liver section of untreated
chickens, stained with H&E. An extensive area of inflammatory infiltrate
can be seen (arrows) next to a vessel (arrowhead). (F) Same visual field
observed by polarized microscopy. (G) Liver section stained with H&E
of treated chickens. A predominantly mixed mononuclear
inflammatory infiltrate can be observed (arrow). (H) Same visual field
observed by polarized microscopy. Note less birefringent material in










Figure 10 Serum biochemistry of chickens infected with
Plasmodium gallinaceum, treated (black bars) or not (gray bars)
with aminoguanidine, and grouped by parasitemia ranges (PR).
(A) ALT, (B) AST, (C) ALP. For noninfected chickens, n = 6 for
untreated and n = 7 for treated; for PR of 1–10, n = 7 for untreated
and n = 6 for treated; for PR of 11–20, n = 6 for untreated and n = 4
for treated; for PR of 31–40, n = 6 for untreated and n = 5 for treated;
for PR of 41–50, n = 5 for untreated and n = 4 for treated; for chronic
chickens, n = 13 for untreated and n = 15 for treated. #Statistically
significant (p < 0.05 or p < 0.01 for ##) in relation to the noninfected
value; *Statistically significant (p < 0.05) in relation to the respective
untreated value. Data are from two independent experiments.
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tions examined.
The higher parasitemia observed in AG treated chickens
may be caused by a reduced capacity to uptake infected
erythrocytes by spleen and liver macrophages that may
extend the presence of infected erythrocytes in the blood.
This is corroborated by lower levels of hemozoin in thespleen and liver of treated chickens. In addition, AG treat-
ment caused lower phagocytic activity of rat macrophages
[43], suggesting that the mechanism that increased
erythrocyte in blood may be related to a reduced uptake
capacity of chicken macrophages. The possibly lower
uptake of infected erythrocytes by the spleen and liver
of treated chickens may also explain the reduced
levels of anemia found in these chickens. Another
possible explanation for the higher parasitemia in
AG-treated chickens may be the reduced capacity to
control parasite growth. NO is a potential microbici-
dal agent [19,21,44,45] and blocking its production, as
seen by the reduced plasma NO levels, indicates that
Macchi et al. Veterinary Research 2013, 44:8 Page 12 of 14
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to persist in infected erythrocytes. In addition, less NO
may cause parasites to increase in the entire tissue,
resulting in a higher infection of erythrocytes.
The analysis of the red series parameters indicates that
infection with P. gallinaceum induces a hypochromic
macrocytic anemia. Although chickens of the AG group
had higher parasitemia, they were less anemic. The MCV
index, in particular, was reduced in treated chickens with
higher parasitemia, when compared to untreated chickens.
This difference in anemia can also be explained by a pos-
sibly lower uptake of infected erythrocytes by treated chick-
ens, as discussed above, or lower lysis of these cells, caused
by less NO. The observation of immature erythrocytes in
the peripheral blood is a confirmation of the bone marrow’s
response to the infection. Plasmodium juxtanucleare,
another avian plasmodium, infects only mature erythro-
cytes [46,47], rarely reaching higher parasitemia levels [12].
The higher aggressiveness of P. gallinaceum, in relation to
P. juxtanucleare, may also involve the capacity of the
former to infect erythrocytes in all states of maturation.
Plasmodium gallinaceum also infects monocytes, hetero-
phils and thrombocytes. Monocytes and heterophils are
professional phagocytes [48,49] and may actively up take
free parasites or hemozoin in the blood after lysis of
erythrocytes. This has been seen in the blood smears of
human subjects, in monocytes and neutrophils [27,50].
However, thrombocytes are not professional phagocytes
[41] and the presence of parasites in these cells indicates
the entrance of P. gallinaceum by active invasion.
A tendency to reduce the number of total leukocytes
was seen with the infection of the chickens. However, a
significant reduction of lymphocytes and heterophils was
observed with the increase in parasitemia. Thus, the
infection by P. gallinaceum reduced the number of some
blood leukocytes. Children infected with P. falciparum
have low lymphocyte counts due to spleen sequestration
[27]. Thus, the leukopenia seen in P. gallinaceum-infected
chickens may also be caused by tissue sequestration,
especially of lymphocytes and heterophils. Monocytes
displayed a different behavior probably explained by tissue
sequestration at the beginning of the infection and faster
recovery in relation to the other two leukocytes. This
recovery may be related to hemozoin accumulation in
tissue that induces monocyte chemokine secretion [51].
As hemozoin accumulates in the tissues of chickens, higher
levels of chemokines may attract monocytes to the tissues
and also increase the production of these cells in the bone
marrow, compensating quantities in the blood. A similar
response may occur in treated chickens but with a
shorter time course. Further studies are necessary to
better understand the fluctuation in the number of
monocytes observed in both chicken groups. Another
interesting result was the recovery of the number ofleukocytes in chickens that became chronic, especially
in the untreated group, which presented leukocytosis
in relation to noninfected chickens. Data indicate that
the inflammatory response in untreated chickens was
elevated, resulting in high numbers of leukocytes in
the blood during chronification.
Infection caused lymphocytes to increase in size and
heterophils became toxic. The morphological changes of
lymphocytes and heterophils with the infection indicate
that these cells also became activated during the infection.
These changes show that the immune system of chickens
was generally activated by the infection, as suggested be-
fore [13]. Eosinophils make an important contribution to
inflammation and the immune response; however, the
function of avian eosinophils is not very well known
[52,53]. It has been suggested that avian eosinophils may
be involved in the early stage of acute inflammation [54]. It
has also been demonstrated that eosinophils participate in
the rat liver granuloma induced by P. berghei [55]. Children
infected with malaria, however, have lower eosinophil
numbers [27]. Eosinophils disappeared from the blood in
the chicken malaria model, studied herein, indicating
that the P. gallinaceum infection of chickens nega-
tively modulates eosinophils right at the beginning of
the infection process, indicating that this cell type is
not involved in the pathogenesis of this disease.
As for the other malaria models [56,57], thrombo-
cytopenia was also seen after infection of the chickens.
Interestingly, AG treatment reduced thrombocytopenia;
no significant difference in total thrombocyte number
was found when compared to noninfected chickens. The
reduction in the number of thrombocytes in untreated
chickens may be related to the greater inflammation
caused by the infection, which may induce a higher
consumption of thrombocytes. Moreover, in severe human
malaria, vasculitis [58,59] and disseminated intravascular
coagulation [60,61] are pathological manifestations that
consume platelets and may also occur in infected chickens.
Another effect of AG may be related to the reduced
vasodilation effect in chickens [35]. This effect would
reduce tissue edema, which is a seminal characteristic of
inflammation [62]. Less edema maintains the perfusion of
tissues, which would help the animal to better survive the
infection. AG treatment may ameliorate vasodilation,
vasculitis and disseminated intravascular coagulation,
explaining the lower thrombocytopenia. This throm-
bocytopenia, together with the lower anemia and lower
general inflammation, may explain the lower death rate
observed in treated chickens.
In addition, the infection caused an increase in
thrombocyte size, and in the appearance of thrombocytes
with long and double nuclei. These atypical cells were
confirmed as thrombocytes by immunofluorescence.
Culture helped in the identification of the atypical
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strate [63]. After observing these atypical thrombocytes,
the blood smears were also re-examined and thrombo-
cytes with double nuclei were also seen. The long and
double nuclei may be evidence of immature thrombocytes
being released into the blood, due to the consumption of
these cells by the infection. As far as we know, this is
the first description of atypical thrombocytes present
in blood in chickens.
Serum biochemistry revealed few changes between the
chicken groups and the chicken with higher parasitemia.
Higher AST, lower ALP and the tendency to increase
urea and uric acid with the infection suggest that the
liver and the kidney were affected by the infection [64].
In conclusion, anemia, thrombocytopenia and inflamma-
tion are factors that result in host death in avian malaria.
The administration of AG blocks NO, leading to a higher
survival rate of the chickens and higher parasitemia. The
improved survival of AG treated chickens may be due to
lower inflammation, anemia and thrombocytopenia. The
study of NO is important for furthering the understanding
of the pathophysiology of malaria and inhibition of
NO signaling may be an extra therapeutic approach
for severe malaria.
Additional file
Additional file 1: Abnormal rhythm vocalization of chickens
infected with Plasmodium gallinaceum.The video shows a chicken
from the untreated group with a clear abnormal rhythm vocalization
(Additional file 1).
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